Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple SclerosisNew England Journal of MedicineSeptember 19, 201210.1056/nejmoa1114287Cited by 1,703SaveCiteExport RISWatch citationsRelated PapersNo related papers foundPowered by citation graph analysis